Prevalence of Helicobacter pylori in patients with nasal polyps: a preliminary report

Can Koc1, Osman Kursat Arikan, Pnar Atasoy

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Kirikkale University, Kirikkale, Turkey.

The Laryngoscope
|October 29, 2004
PubMed
Abstract

Insights

Helicobacter pylori (H. pylori) was found in a higher prevalence in nasal polyps compared to control tissues, suggesting a potential link. Further research is needed to confirm these findings and understand the role of H. pylori in nasal polyps.

Area of Science:

  • Otolaryngology
  • Microbiology
  • Immunology

Background:

  • Nasal polyps are inflammatory growths in the nasal cavity.
  • The role of bacterial infections in the development of nasal polyps is not fully understood.
  • Helicobacter pylori (H. pylori) is a bacterium commonly associated with gastrointestinal diseases.

Purpose of the Study:

  • To investigate the presence of H. pylori in nasal polyps.
  • To compare H. pylori prevalence in nasal polyps versus control nasal tissues.
  • To evaluate the association between H. pylori infection and nasal polyposis.

Main Methods:

  • A prospective, controlled clinical trial involving 30 patients with nasal polyps and 20 controls.
  • Detection of anti-H. pylori specific immunoglobulin (IgG) antibodies in serum using enzyme-linked immunosorbent assay (ELISA).
  • Immunohistochemical analysis of nasal polyp and control tissue specimens for H. pylori presence.

Main Results:

  • H. pylori specific IgG antibodies were detected in 86.7% of polyp patients and 85% of controls via ELISA.
  • H. pylori was identified in 20% of nasal polyp tissues but not in control tissues.
  • Immunohistochemical staining showed a statistically significant difference in H. pylori presence between nasal polyps and control tissues (P = .037).

Conclusions:

  • H. pylori infection appears to be more prevalent in nasal polyps than in healthy nasal mucosa.
  • The findings suggest a potential association between H. pylori and the pathogenesis of nasal polyps.
  • Further epidemiological studies are required to confirm these results and elucidate the underlying mechanisms.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...